Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia

B. Jones, Peter; R. E. Barnes, Thomas; Davies, Linda; Dunn, Graham; Lloyd, Helen; P. Hayhurst, Karen; Murray, Robin; Markwick, Alison; Lewis, Shôn

doi:10.1001/archpsyc.63.10.1079

Public

Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia

Published in Archives of General Psychiatry • Oct 1, 2006

Authors:

Peter B. Jones

Thomas R. E. Barnes

Linda Davies

Abstract

CONTEXT: Second-generation (atypical) antipsychotics (SGAs) are more expensive than first-generation (typical) antipsychotics (FGAs) but are perceived to be more effective, with fewer adverse effects, and preferable to patients. Most evidence comes from short-term efficacy trials of symptoms. OBJECT...

Subject

Schizophrenia (object-oriented programming)

Clozapine

Randomized controlled trial

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!